Tulsa Wealth Advisors »

Galectin Therapeutics shares owned by Tulsa Wealth Advisors

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Tulsa Wealth Advisors from 13F filings

Historical chart of Tulsa Wealth Advisors investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Tulsa Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Tulsa Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $97k 23k 4.16

More positions owned by Tulsa Wealth Advisors

Broadcom Incorporated Common Stock (AVGO)
Apple Incorporated Common Stock (AAPL)
Microsoft Corporation Common Stock (MSFT)
Jpmorgan Chase & Company. Common Stock (JPM)
Walmart Incorporated Common Stock (WMT)
Motorola Solutions Incorporated Common Stock (MSI)
Alphabet Incorporated Cap Stk Class A Common Stock (GOOGL)
Home Depot Incorporated Common Stock (HD)
Analog Devices Incorporated Common Stock (ADI)
Cme Group Incorporated Common Stock (CME)
Marathon Pete Corporation Common Stock (MPC)
Johnson & Johnson Common Stock (JNJ)
Oneok Incorporated Common Stock (OKE)
Amazon Com Incorporated Common Stock (AMZN)
Nvidia Corporation Common Stock (NVDA)

View all positions for Tulsa Wealth Advisors

Top funds holding Galectin Therapeutics

Vanguard Group
Advisor Group Holdings
Susquehanna International
BlackRock
Marshall Wace
Sontag Advisory
Geode Capital Management
Jane Street
Commonwealth Equity Services
LPL Financial
Goldman Sachs Group
Geneos Wealth Management
State Street Corporation
Sovran Advisors
Vivaldi Capital Management

View all funds holding Galectin Therapeutics